Some Inhibitors of Deamination of 9-β-d-Arabinofuranosyladenine and 9-β-d-Xylofuranosyladenine by Blood and Neoplasms of Experimental Animals and Humans
暂无分享,去创建一个
[1] D. B. Ellis,et al. Metabolic fate of 9-beta-d-xylofuranosyladenine in mice bearing susceptible tumor cells. , 1966, Cancer research.
[2] G. Beisenherz,et al. Absorption and activity of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (RA8) following enteric administration. , 1965, Archives internationales de pharmacodynamie et de therapie.
[3] D. B. Ellis,et al. Some inhibitory effects of 9-beta-D-xylofuranosyladenine, an adenosine analog, on nucleotide metabolism in ascites tumor cells. , 1965, Molecular Pharmacology.
[4] G. Lepage,et al. METABOLISM OF PURINE NUCLEOSIDE ANALOGS. , 1965, Cancer research.
[5] T. Mellinger,et al. Pathways and tissue distribution of dipyridamole (Persantin). , 1965, Archives internationales de pharmacodynamie et de therapie.
[6] J. Brink,et al. METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES. , 1964, Cancer research.
[7] R. Berne,et al. Influence of a Pyrimidopyrimidine Derivative on Deamination of Adenosine by Blood , 1964, Circulation research.
[8] A. Coddington,et al. THE FORMATION OF DEOXYADENOSINE TRIPHOSPHATE IN ASCITES-TUMOUR CELLS IN VITRO AND ITS EFFECT ON DEOXYRIBONUCLEIC ACID SYNTHESIS. , 1963, Biochimica et biophysica acta.
[9] J. Robinson. Some effects of glucose and calcium upon the metabolism of kidney slices from adult and newborn rats. , 1949, Biochemical Journal.